登记号
                                CTR20223121
                                相关登记号
                                
                                曾用名
                                
                                药物类型
                                
                                    生物制品                                
                                临床申请受理号
                                企业选择不公示
                                适应症
                                类风湿关节炎
                                试验通俗题目
                                一项在中重度活动性类风湿关节炎成人受试者中评价peresolimab的2b期研究
                                试验专业题目
                                一项在中重度活动性类风湿关节炎成人受试者中评价peresolimab的2b期、双盲、安慰剂对照研究
                                试验方案编号
                                J1A-MC-KDAF
                                方案最近版本号
                                e
                                版本日期
                                2023-05-31
                                方案是否为联合用药
                                否
                            申请人信息
申请人名称
                                
                                联系人姓名
                                朱彤
                                联系人座机
                                021-23021370
                                联系人手机号
                                15021603639
                                联系人Email
                                zhu_tong@lilly.com
                                联系人邮政地址
                                上海市-上海市-静安区石门一路288号太古汇一座19层
                                联系人邮编
                                200041
                            临床试验信息
试验分类
                                
                                    安全性和有效性                                
                                试验分期
                                
                                    II期                                
                                试验目的
                                根据达到ACR20的受试者比例,评价peresolimab与安慰剂相比的有效性
                                随机化
                                
                                    随机化                                
                                盲法
                                
                                    双盲                                
                                试验范围
                                
                                    国际多中心试验                                
                                设计类型
                                
                                    平行分组                                
                                年龄
                                18岁(最小年龄)至
										无上限
										(最大年龄)
                                性别
                                男+女
                                健康受试者
                                
                                    无                                
                                入选标准
                                - 签署知情同意时受试者年龄≥18岁。
 - 根据2010 年美国风湿病学会(ACR)/欧洲抗风湿病联盟(EULAR)分类标准的定义,在筛选前≥3个月确诊为RA的成人患者。
 - 筛选和基线时存在中重度活动性RA。
 - 对至少一种传统合成DMARD(csDMARD)或生物制剂DMARD(bDMARD)或靶向合成DMARD(tsDMARD)应答不佳或失应答或不耐受。
 
排除标准
                                - 根据ACR标准,存在IV类RA。
 - 根据研究者的判断,存在一种或多种重大合并症,包括但不限于: 控制不佳的糖尿病或高血压 慢性肾脏病 IIIb 期、IV 期或 V 期 纽约心脏协会 II 级、III 级或 IV 级症状性心力衰竭 随机化前 12 个月内发生过心肌梗死、不稳定型心绞痛、卒中或短暂性脑缺血发作 重度慢性肺病,例如,需要氧疗 除 RA 外的重大慢性炎症性疾病或结缔组织疾病,包括但不限于: o 系统性红斑狼疮 o 银屑病关节炎 o 中轴型脊柱关节炎 o 反应性关节炎 o 痛风 o 硬皮病 o 多发性肌炎 o 皮肌炎 o 活动性纤维肌痛,或 o 多发性硬化。
 
试验分组
试验药
                                | 名称 | 用法 | 
|---|---|
| 
                                                 
													中文通用名:无 
                                             | 
                                            
                                                 
													 剂型:注射剂 
                                             | 
                                        
| 
                                                 
													中文通用名:无 
                                             | 
                                            
                                                 
													 剂型:注射剂 
                                             | 
                                        
| 
                                                 
													中文通用名:无 
                                             | 
                                            
                                                 
													 剂型:注射剂 
                                             | 
                                        
对照药
                                | 名称 | 用法 | 
|---|---|
| 
                                                 
													中文通用名:安慰剂 
                                             | 
                                            
                                                 
													 剂型:注射剂 
                                             | 
                                        
| 
                                                 
													中文通用名:安慰剂 
                                             | 
                                            
                                                 
													 剂型:注射剂 
                                             | 
                                        
终点指标
主要终点指标
                                | 指标 | 评价时间 | 终点指标选择 | 
|---|---|---|
| 第12周达到ACR20的受试者比例 | 第12周 | 有效性指标 | 
次要终点指标
                                | 指标 | 评价时间 | 终点指标选择 | 
|---|---|---|
| 评价peresolimab与安慰剂相比对疾病活动指标的影响 | 第12周 | 有效性指标 | 
| 评价peresolimab与安慰剂相比对患者报告结局指标的影响 | 第12周 | 有效性指标 | 
| 评价peresolimab对疾病活动指标的影响 | 第12周 | 有效性指标 | 
| 确定peresolimab的药代动力学特征 | 第12周 | 有效性指标+安全性指标 | 
数据安全监察委员会(DMC)
                                
                                    无                                
                                为受试者购买试验伤害保险
                                研究者信息
| 姓名 | 学位 | 职称 | 电话 | 邮政地址 | 邮编 | 单位名称 | |
|---|---|---|---|---|---|---|---|
| 邹和建 | 医学博士 | 主任医师 | 13311881366 | mail@hjzou.com | 上海市-上海市-乌鲁木齐中路12号 | 200040 | 复旦大学附属华山医院 | 
各参加机构信息
| 机构名称 | (主要)研究者 | 国家 | 地区 | 城市 | 
|---|---|---|---|---|
| 复旦大学附属华山医院 | 邹和建 | 中国 | 上海市 | 上海市 | 
| 蚌埠医学院第一附属医院 | 李志军 | 中国 | 安徽省 | 蚌埠市 | 
| 四川大学华西医院 | 赵毅 | 中国 | 四川省 | 成都市 | 
| 中南大学湘雅医院 | 李通 | 中国 | 湖南省 | 长沙市 | 
| 深圳市人民医院 | 刘冬舟 | 中国 | 广东省 | 深圳市 | 
| 萍乡市人民医院 | 胡建康 | 中国 | 江西省 | 萍乡市 | 
| 汕头大学医学院第一附属医院 | 侯志铎 | 中国 | 广东省 | 汕头市 | 
| 中山大学附属第一医院 | 杨念生 | 中国 | 广东省 | 广州市 | 
| 北京大学人民医院 | 周云杉 | 中国 | 北京市 | 北京市 | 
| 华中科技大学同济医学院附属同济医院 | 董凌莉 | 中国 | 湖北省 | 武汉市 | 
| CIPREC Sede Arenales Loc. 60 | Guillermo Bartel | Argentina | Ciudad Autónoma de Buenos Aires | Buenos Aires | 
| Organizacion Medica de Investigacion Loc. 9 | Eduardo Mysler | Argentina | Buenos Aires | CABA | 
| CER San Juan Loc. 30 | Rodolfo Pardo Hidalgo | Argentina | San Juan | San Juan | 
| Centro Privado de Medicina Familiar / Mindout Research Loc. 17 | Leonardo Naftal | Argentina | Buenos Aires | Ciudad Autónoma de Buenos Aires | 
| Centro Medico Privado de Reumatologia Loc. 17 | Walter Spindler | Argentina | Tucumán | SAN M. DE TUCUMAN | 
| Instituto Medico Strusberg Loc. 19 | Marcos Baravalle | Argentina | Córdoba | Córdoba | 
| APRILLUS Asistencia E Investigacion Loc. 19 | Pablo Mannucci Walter | Argentina | Buenos Aires | CABA | 
| Centro de Enfermedades de Hígado y Aparato Digestivo Loc. 3 | Judith Carrio | Argentina | Santa Fe | Rosario | 
| Clinica Adventista Belgrano Loc. 18 | Federico Ariel | Argentina | Buenos Aires | CABA | 
| Fundación Respirar Loc. 54 | ALEJANDRO ARROYO | Argentina | Buenos Aires | Buenos Aires | 
| Hospital Córdoba | Veronica Savio | Argentina | Córdoba | Córdoba | 
| Centre de Recherche Musculo-Squelettique | Frederic Morin | Canada | Quebec | Trois-Rivières | 
| Aggarwal and Associates Limited | Naresh Aggarwal | Canada | Ontario | brampton | 
| G.R.M.O. (Groupe de recherche en maladies osseuses) Inc. | Louis Bessette | Canada | Quebec | Quebec | 
| Clinic of Rheumatology and Clinical Immunology Loc. 1 | Prodromos Sidiropoulos | Greece | Krítí | Heraklion | 
| 2nd Department of Medicine and Laboratory, Clinical Immunology-Rheumatology Unit Loc. 1 | Dimitrios Vassilopoulos | Greece | Attikí | Athens | 
| First Department of Internal Medicine Loc. 1 | Charalampos Papagoras | Greece | évros | ALEXANROUPOLIS | 
| 4th Department of Medicine/ Rheumatology and Immunology Unit Loc. 1 | Dimitrios Boumpas | Greece | Attikí | Chaidari | 
| 1st Department of Propaedeutic Internal Medicine Loc. 1 | PETROS SFIKAKIS | Greece | Attikí | Athens | 
| Qualiclinic | Istvan Szombati | Hungary | Budapest | Budapest | 
| Revita Clinic | Regina Cseuz | Hungary | Pest | Budapest | 
| Vital Medical Center | Edit Drescher | Hungary | Veszprém City | Veszprem | 
| Reumatologia Loc. 1 | Serena Guiducci | Italy | Firenze | Firenze | 
| U.O. Reumatologia Loc. 1 | PIERCARLO SARZI PUTTINI | Italy | Milano | Milan | 
| UOC Reumatologia Loc. 1 | Ombretta Viapiana | Italy | Verona | Verona | 
| Koujunkai Daido Clinic Loc. 3 | Yoichiro Haji | Japan | Aichi | Nagoya | 
| Chubu Rosai Hospital | Yoshiro Fujita | Japan | Aichi | Nagoya | 
| University of Occupational and Enviromental Health | Shingo Nakayamada | Japan | Fukuoka | Kitakyushu | 
| Machida Municipal Hospital | Megumi Hiida | Japan | Tokyo | Tokyo | 
| Tobata General Hospital | Kazuyoshi Saito | Japan | Fukuoka | Kitakyushu | 
| Hiroshima University Hospital | Shintaro Hirata | Japan | Hiroshima | Hiroshima | 
| Yoshida Internal Medicine Clinic | Tomohiko Yoshida | Japan | Nagano | Sakaki | 
| Bayside Misato Medical Center | Yoshinori Taniguchi | Japan | Kochi | Kochi | 
| Tonan Hospital | Kazuaki Katsumata | Japan | Hokkaido | Sapporo | 
| Sagawa Akira Rheumatology Clinic Loc. 3 | AKIRA FURUSAKI | Japan | Hokkaido | Sapporo | 
| Juntendo University Hospital | Michihiro Ogasawara | Japan | Tokyo | Bunkyo-ku | 
| Okayama City General Medical Center Okayama City Hospital | Hiroshi Wakabayashi | Japan | Okayama | Okayama | 
| Hirose Clinic - Tokorozawa | Wataru Hirose | Japan | Saitama | Tokorozawa | 
| Sasebo Chuo Hospital | Yukitaka Ueki | Japan | Nagasaki | Sasebo | 
| Shinkokura Hospital | Hiroshi Tsukamoto | Japan | Fukuoka | Kitakyushu | 
| Hiroshima Clinic | KEISUKE ODA | Japan | Hiroshima | Hiroshima | 
| Clinica de Investigacion en Reumatologia y Obesidad S. C. | Sergio Duran-Barragan | Mexico | Jalisco | Guadalajara | 
| Kohler and Milstein Research S.A. de C.V. Loc. 1 | Jesus Simon Campos | Mexico | Yucatán | Mérida | 
| Clinstile, S.A. de C.V. Loc. 7 | Favio Edmundo Enriquez Sosa | Mexico | Distrito Federal | Mexico | 
| Centro Medico del Angel Loc. 6 | Beatriz Zazueta Montiel | Mexico | Baja California | Mexicali | 
| Investigacion y Biomedicina de Chihuahua | Cesar Pacheco-Tena | Mexico | Chihuahua | Chihuahua | 
| Rheuma Medicus Zaklad Opieki Zdrowotnej | Maria Rell-Bakalarska | Poland | Mazowieckie | Warszawa | 
| Ambulatorium Sp. z o.o. Loc. 7 | Anna Bazela-Ostromecka | Poland | Warmińsko-mazurskie | Elblag | 
| Nova Reuma Spolka Partnerska | Izabela Domyslawska | Poland | Podlaskie | Bialystok | 
| Twoja Przychodnia NCM Loc. 2 | Malgorzata Miakisz | Poland | Lubuskie | Nowa Sol | 
| Centrum Medyczne Reuma Park | Janusz Jaworski | Poland | Mazowieckie | Warszawa | 
| MICS Centrum Medyczne Warszawa Loc. 6 | Katarzyna Romanowska - Prochnicka | Poland | Mazowieckie | Warszawa | 
| Klinika Reumatologii i Ukladowych Chorob Tkanki cznej Loc. 1 | Rafal Wojciechowski | Poland | Kujawsko-pomorskie | Bydgoszcz | 
| NZOZ BIF-MED | Hanna Mastalerz | Poland | Slaskie | Bytom | 
| ai centrum medyczne sp. z o.o. sp.k. | Anna Rychlewska-Hanczewska | Poland | Wielkopolskie | Poznan | 
| Twoja Przychodnia Poznanskie Centrum Medyczne | Agata Wytyk-Nowak | Poland | Wielkopolskie | Poznań | 
| Rheumatology Loc. 1 | Maria Luz Garcia Vivar | Spain | País Vasco | Bilbo | 
| Unidad de investigacion de Reumatologia Loc. 1 | JUAN SANCHEZ BURSON | Spain | Sevilla | Sevilla | 
| CHUAC-Complejo Hospitalario Universitario A Coruna | Francisco Javier Blanco Garcia | Spain | A Coruna | A Coruna | 
| Hospital Universitario Marqués de Valdecilla | Ricardo Blanco | Spain | Cantabria | Santander | 
| Clínica Gaias - Santiago | Juan Gomez-Reino | Spain | A Coruna | Santiago de Compostela | 
| Clinical Trial Unit - Rheumatalogy department Loc. 1 | Antonio Mera Varela | Spain | Galicia [Galicia] | Santiago de Compostela | 
| Albuquerque Clinical Trials, Inc. Loc. 4 | Satkirin Khalsa | United States | New Mexico | Albuquerque | 
| Physician Research Collaboration, LLC Loc. 4 | Melvin Churchill | United States | Nebraska | Lincoln | 
| Latin Clinical Trial Center Loc. 8 | Carlos Pantojas | United States | Puerto Rico | San Juan | 
| Medvin Clinical Research - Metyas Loc. 4 | Samy Metyas | United States | California | Covina | 
| East Bay Rheumatology Medical Group, Inc Loc. 7 | Suneet Grewal | United States | California | San Leandro | 
| Desert Medical Advances Loc. 6 | Maria Greenwald | United States | California | Palm Desert | 
| Paramount Medical Research & Consulting, LLC Loc. 3 | Isam Diab | United States | Ohio | Middleburg Heights | 
| Accurate Clinical Management - Houston Loc. 4 | Amber Khan | United States | Texas | Houston | 
| Medvin Clinical Research - Su Loc. 1 | Tien-I Su | United States | California | Whittier | 
| Mindful Medical Research Loc. 4 | Oscar Soto-Raices | United States | Puerto Rico | San Juan | 
| Saint Louis Rheumatology Loc. 1 | Chad Ronholm | United States | Missouri | St. Louis | 
| Rheumatology Loc. 1 | AMARILIS PEREZ DE JESUS | United States | Puerto Rico | caguas | 
| Denver Arthritis Clinic Loc. 5 | Christopher Antolini | United States | Colorado | Denver | 
| Arizona Arthritis & Rheumatology Research, PLLC Loc. 9 | Swati Bharadwaj | United States | Arizona | Mesa | 
| Accurate Clinical Research Loc. 14 | Philip Waller | United States | Texas | Houston | 
| DM Clinical Research Loc. 5 | Shaikh Ali | United States | Texas | Tomball | 
| Arthritis Consultants, Inc. Loc. 6 | Akgun Ince | United States | Missouri | Saint Louis | 
| Piedmont Arthritis Clinic Loc. 2 | Jeffrey Lawson | United States | South Carolina | Greenville | 
| Arizona Arthritis & Rheumatology Research, PLLC Loc. 9 | Nehad Soloman | United States | Arizona | Phoenix | 
| Research Loc. 7 | Leroy Pacheco | United States | New Mexico | Albuquerque | 
| Great Lakes Clinical Trials - Ravenswood Loc. 1 | Manish Jain | United States | Illinois | Chicago | 
| Clinical Research of West Florida Loc. 2 | Priya Reddy, MD | United States | Florida | Tampa | 
| AA Medical Research Center Loc. 3 | ALI KARRAR | United States | Michigan | Grand Blanc | 
| Rheumatology & Pulmonary Clinic Loc. 2 | Wassim Saikali | United States | West Virginia | Beckley | 
| Encore Medical Research of Boynton Beach Loc. 1 | Jude Acloque | United States | Florida | Boynton Beach | 
| Advanced Rheumatology, PC Loc. 3 | Monika Mohan | United States | Michigan | Lansing | 
| Arthritis & Osteoporosis Associates - Freehold Loc. 3 | Hisham El-Kadi | United States | New Jersey | Freehold | 
| DJL Clinical Research, PLLC Loc. 5 | Emily Box | United States | North Carolina | Charlotte | 
| Tekton Research, Inc Loc. 3 | Paul Pickrell | United States | Texas | Austin | 
| Clinical Research Loc. 3 | David Snow | United States | North Carolina | Leland | 
| Accurate Clinical Management Loc. 2 | Sabeen Najam | United States | Texas | Baytown | 
| DM Clinical Research/Rheumatology Clinic of Houston Loc. 3 | Qaisar Rehman | United States | Texas | Tomball | 
| ForCare Clinical Research Loc. 3 | Tanya Bogle | United States | Florida | Tampa | 
| Accurate Clinical Research Loc. 13 | Enrique Mendez | United States | Louisiana | Lake Charles | 
| Great Lakes Research Group, Inc. Loc. 10 | Jeffrey Potts | United States | Michigan | Bay City | 
| NYU Langone Ambulatory Care Brooklyn Heights Loc. 1 | David Goddard | United States | New York | Brooklyn | 
| West Virginia Research Institute Loc. 4 | Suzanne Gharib | United States | West Virginia | South Charleston | 
| Dan La, MD Inc Loc. 2 | DAN LA | United States | California | Tujunga | 
| Primary Care & Rheumatology TAMPA Loc. 1 | Michael Burnette | United States | Florida | Tampa | 
| BMG Rheumatology Suncoast Loc. 1 | Sonialy Lugo-Ruiz | United States | Florida | St. Petersburg | 
| Arizona Arthritis & Rheumatology Research PLLC Loc. 4 | Joonhee Lim | United States | Arizona | Gilbert | 
| Accel Research Sites – Birmingham Clinical Research Unit Loc. 1 | Hayes Williams | United States | Alabama | Birmingham | 
| Health Research of Oklahoma Loc. 5 | Christine Codding | United States | Oklahoma | Oklahoma City | 
| HARAC Research Corp Loc. 1 | Alexander Torres | United States | Florida | Avon Park | 
| Clinical Research of West Florida, Inc. (Clearwater) Loc. 3 | Rodney Daniel | United States | Florida | Clearwater | 
| Arizona Arthritis & Rheumatology Research, PLLC Loc. 8 | Mona Amin | United States | Arizona | Glendale | 
| GCM Medical Group, PSC - Hato Rey Site Loc. 6 | Karina Vila-Rivera | United States | Puerto Rico | San Juan | 
| West Broward Rheumatology Associates Loc. 2 | Elias Halpert | United States | Florida | Tamarac | 
| Sound Clinical Research, LLC Loc. 2 | Jeff Peterson | United States | Washington | Bothell | 
| Wolverine Clinical Trials Loc. 1 | Behnam Khaleghi | United States | California | Santa Ana | 
| Clinvest Research LLC | David True | United States | Missouri | Springfield | 
| Newport Huntington Medical Group Loc. 1 | Christine Thai | United States | California | Huntington Beach | 
| altoona center for clinical research Loc. 4 | Alan Kivitz | United States | Pennsylvania | Duncansville | 
| Arthritis and Rheumatology Center of MI - Rochester Hills Loc. 1 | Srijana Pradhan Bakshi | United States | Michigan | Rochester Hills | 
| Rheumatology Loc. 1 | Shirley Pang | United States | California | Fullerton | 
| Research Loc. 7 | Christopher Wright | United States | Washington | Spokane | 
| Suncoast Clinical Research, Inc. | Farrukh Zaidi | United States | Florida | New Port Richey | 
伦理委员会信息
| 名称 | 审查结论 | 审查日期 | 
|---|---|---|
| 复旦大学附属华山医院伦理审查委员会 | 同意 | 2022-11-02 | 
| 复旦大学附属华山医院伦理审查委员会 | 同意 | 2022-12-16 | 
| 复旦大学附属华山医院伦理审查委员会 | 同意 | 2023-03-08 | 
| 复旦大学附属华山医院伦理审查委员会 | 同意 | 2023-05-05 | 
| 复旦大学附属华山医院伦理审查委员会 | 同意 | 2023-06-21 | 
试验状态信息
试验状态
                                
                                    主动终止                                
                                目标入组人数
                                国内: 28 ;
											国际: 420 ;
                                已入组例数
                                国内: 25 ;
										国际: 491 ;
                                实际入组总例数
                                国内: 25  ;
										国际: 491 ;
                                第一例受试者签署知情同意书日期
                                国内:2023-02-16;    
										国际:2022-08-31;
                                第一例受试者入组日期
                                国内:2023-04-28;    
										国际:2022-11-14;
                                试验终止日期
                                国内:2024-09-20;    
										国际:2024-09-20;
                            临床试验结果摘要
| 版本号 | 版本日期 | 
|---|